U.S. Agent
Initial Importer and FDA Representation
for medical devices and IVDs

The reference partner for the US market

Foreign medical device and IVD establishments involved in manufacturing, preparing, propagating, compounding, assembling or processing devices intended for import into the United States may be required to register with the FDA and designate a U.S. Agent as part of the FDA establishment registration process.

The FDA U.S. Agent acts as the U.S.-based contact for communication between the FDA and the foreign establishment. The role includes supporting FDA communications, assisting with questions concerning devices imported or offered for import into the United States, helping arrange FDA inspections when requested, and receiving FDA communications when the foreign establishment cannot be contacted directly or promptly.

For foreign manufacturers without a physical presence in the United States, the designation of a reliable U.S. Agent is an important element of the U.S. regulatory access structure. However, the U.S. Agent role does not replace the manufacturer’s own regulatory obligations, including applicable premarket submission requirements, quality system compliance, labeling compliance, Medical Device Reporting, corrections and removals, registration maintenance, device listing accuracy, or other FDA requirements applicable to the device and the manufacturer.

ALTRION supports foreign manufacturers of medical devices and IVDs with U.S. Agent designation, FDA establishment registration, device listing support, regulatory communication with the FDA, coordination of registration-related information, optional Initial Importer support where applicable, and inspection readiness assistance. The service is designed to help companies manage U.S. market access with a clear regulatory structure and a reliable point of contact for FDA-related communications.

FDA U.S. Agent designation and FDA registration

ALTRION supports foreign manufacturers in the formal designation of the FDA U.S. Agent and assists with FDA registration activities, including the collection and organization of the information required for establishment registration and device listing.

This may include support with FDA registration account information, FEI-related information where applicable, owner/operator details, establishment data, device information, product codes, activities performed by the establishment, and other registration-related elements.

A properly designated U.S. Agent provides a clear communication channel between the FDA and the foreign establishment. ALTRION helps manufacturers structure this designation and maintain the information needed for registration and ongoing regulatory correspondence.

Establishment Registration and Device Listing

Foreign medical device and IVD establishments may need to complete FDA Establishment Registration and Device Listing before placing products on the U.S. market, depending on their activities and the type of device involved.

ALTRION supports these activities by helping manufacturers manage the registration process and list the relevant devices in the FDA system. This includes reviewing the consistency of device information, product codes, regulatory status, establishment activities and manufacturer details.

Accurate establishment registration and device listing information is essential to maintain visibility and traceability within the FDA system. It also supports market access, importation checks, regulatory monitoring and future updates connected to the manufacturer or its products.

510(k), De Novo and FDA submission support

Where required by the applicable regulatory pathway, ALTRION can support the review, preparation or update of FDA submissions, including 510(k) or De Novo documentation.

This service is separate from the U.S. Agent role, but it can be integrated into the overall U.S. market access strategy. Submission support may be useful when product documentation, device listing, product codes, intended use, technological characteristics or market access activities must remain consistent with the regulatory status of the device.

By connecting U.S. Agent services with FDA submission support where needed, ALTRION helps manufacturers maintain a coherent regulatory file and reduce the risk of inconsistencies between registration, device listing, submission documentation and market access activities.

Customs and importation coordination

Importation is a key operational step for foreign manufacturers entering the U.S. market. FDA registration and device listing information must be consistent with the way products are imported and distributed in the United States.

ALTRION can support coordination with importation, logistics and customs partners from a regulatory perspective, helping manufacturers organize the information needed for product entry into the United States.

This service may include support in aligning importation documentation with FDA registration and device listing information, clarifying the parties involved in the importation chain, and coordinating communication between the manufacturer, U.S. Agent, Initial Importer, distributor, logistics provider and other relevant parties.

Initial Importer support

Depending on the distribution model, an Initial Importer may also be involved in the U.S. market access structure. The Initial Importer is connected to the importation and distribution pathway, while the FDA U.S. Agent acts as the U.S.-based contact for FDA communication with the foreign establishment.

These are separate roles and should be evaluated based on the actual business model, importation route, contractual structure and distribution responsibilities.

ALTRION can help manufacturers assess whether an Initial Importer role is needed and, where applicable, support the coordination or designation of an Initial Importer for distribution-related purposes.

FDA inspections and communications

ALTRION supports foreign manufacturers during FDA communications and inspection-related activities. This may include assisting with communication management, inspection scheduling, preparation of relevant information and coordination between the FDA and the foreign establishment.

For foreign manufacturers, having a reliable U.S.-based contact helps improve responsiveness and reduce delays in FDA communications. ALTRION supports companies in keeping communication clear, documented and aligned with FDA expectations.

FAQ about FDA U.S. Agent

An FDA U.S. Agent is a U.S.-based contact designated by a foreign medical device or IVD establishment as part of the FDA establishment registration process. The U.S. Agent supports communication between the FDA and the foreign establishment.

Foreign establishments involved in manufacturing or processing medical devices or IVDs intended for import into the United States may be required to register with the FDA and designate a U.S. Agent, depending on their activities and regulatory obligations.

ALTRION supports U.S. Agent designation, FDA establishment registration, device listing, registration-related information management, communication with the FDA, inspection scheduling support, importation coordination and inspection readiness activities.

No. The U.S. Agent does not replace the manufacturer’s own regulatory obligations. The manufacturer remains responsible for applicable FDA requirements, including premarket submissions where required, quality system compliance, labeling compliance, Medical Device Reporting, corrections and removals, registration maintenance and device listing accuracy.

The U.S. Agent is the U.S.-based contact for FDA communication with the foreign establishment. The Initial Importer is connected to the importation and distribution of the device in the United States. Depending on the distribution model, both roles may be relevant, but they are separate and have different regulatory implications.

Yes. ALTRION can support the review, preparation or update of FDA submissions, including 510(k) or De Novo documentation, where applicable. This support can be integrated with registration, device listing and broader U.S. market access activities.

Yes. ALTRION supports foreign manufacturers of medical devices and IVDs with U.S. Agent designation, FDA registration and listing support, importation coordination and regulatory communication activities.

Why choose ALTRION

ALTRION provides practical regulatory support for foreign medical device and IVD manufacturers entering or maintaining access to the U.S. market.

The service combines U.S. Agent designation with FDA registration, device listing support, importation coordination and, where required, FDA submission support. This allows manufacturers to manage U.S. market access through a more structured and coordinated regulatory pathway.

ALTRION’s approach is designed to help manufacturers keep regulatory information consistent across establishment registration, device listing, importation activities, FDA communications and submission documentation. This is particularly useful for companies managing multiple products, product codes, distributors, importation partners or regulatory pathways.

Deliverables

ALTRION provides the key regulatory outputs needed to formalize the U.S. Agent designation, support FDA registration and maintain inspection readiness.

Typical deliverables may include:

  • U.S. Agent Appointment Letter and confirmation of U.S. Agent designation in the FDA registration system.
  • Support for FDA Establishment Registration and Device Listing.
  • Registration and listing information review.
  • Support with FEI-related information, owner/operator information and establishment data.
  • Annual registration maintenance support.
  • FDA communication and inspection scheduling support.
  • Importation coordination support from a regulatory perspective.
  • Optional Initial Importer coordination or designation support, where applicable.
  • Inspection readiness package and regulatory communication support.

Bring your medical devices to the United States

Fill out the form with your request.

We will contact you as soon as possible.

Contact form

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

© Copyright 2026 - Altrion - All rights reserved